Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

11.21
Delayed Data
As of Apr 29
 -0.27 / -2.35%
Today’s Change
6.51
Today|||52-Week Range
17.54
+13.23%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close11.48
Today’s open11.42
Day’s range10.98 - 11.50
Volume639,646
Average volume (3 months)926,303
Market cap$915.9M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-50.57%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+4.08%
P/E ratioNM
Price/Sales4.36
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc-0.58-1.17%
MMSIMerit Medical System...+0.58+2.95%
ABAXAbaxis Inc+0.66+1.48%
LMNXLuminex Corp+0.13+0.63%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$153.6M
Annual profit (last year)-$50.4M
Net profit margin-32.83%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts

Partner Offers

Search for Jobs